Skip to main content
  • Lone star tick research

    Using Collaboration to Fight a Tricky Tick-Borne Disease

    Alpha-Gal Syndrome, or AGS, is a recently identified tick-borne disease that triggers an allergy to red meat and other products made from mammals, including cheese, gelatin, and medications like heparin. Since its discovery in 2009, cases in the United States alone have risen from 24 to >40,000 people, owing to the geographic spread of the tick populations and the fact that th … Continued

  • The Complex Challenges of COVID-19 Prevention Among Jails in the South

    Since the start of the pandemic, people in jail have faced an inequitably high risk of SARS-CoV-2 infection. Overcrowding and lack of hygiene supplies have left jail populations particularly vulnerable to outbreaks, while frequent population turnover has made it difficult to prevent and track the spread of new variants. In addition, racial incarceration disparities and frequent C … Continued

  • Emily Duberman Leads With Compassion Providing Tools that Empower

    Social workers promote individual and community wellbeing, supporting people through some of life’s most difficult challenges. Emily Duberman, LCSW, CHES, is the Ryan White Lead Social Worker at the UNC Eastowne Infectious Diseases Clinic. She says it’s particularly gratifying to witness patients grow in independence and empowerment.

  • david-weber

    Dr. Weber Elected President of the Society for Healthcare Epidemiology of America

    David Weber, MD, MPH, was elected as the incoming vice president of the Society for Healthcare Epidemiology of America (SHEA) during the group’s meeting held in conjunction with Infectious Diseases Week, an international conference, in Washington, D.C., in October. David Weber, MD, MPH, was elected as president of the Society for Healthcare Epidemiology of America (SHEA) during t … Continued

  • Could Science Be Synonymous With Courage? The News This Week Is Timely

    As Fischer and Wohl Fight Disease in Sub-Saharan Africa, the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response (ASPR) Selects UNC to be a Regional Emerging Special Pathogen Treatment Center (RESPTC). See press announcement. Many courageous infectious disease specialists and other clinicians have not shied away from caring for tho … Continued

  • Ross Boyce, MD, MSc

    Dr. Boyce Receives Jefferson-Pilot Fellowship in Academic Medicine

    Ross Boyce, MD, MSc, assistant professor in the Division of Infectious Diseases and Department of Epidemiology, has been selected as one of the recipients of the Jefferson-Pilot Fellowships in Academic Medicine. This award is given to exceptional UNC School of Medicine (SOM) junior faculty. “I am honored to receive this award,” said Dr. Boyce. “I know there are many talented and … Continued

  • The Leadership and Teamwork Behind 6 and 8 Bedtower

    From managing the day-to-day operations, ensuring patients receive the highest level of care, budgeting and staffing, our nurse managers are like business owners of their unit. And it takes a team to run a successful business. Nikia Smith, BSN, RN, NE-BC, and Turkeisha Brown, MSN, RN, NE-BC, have both been nurse managers at the University of North Carolina for 12 years. Smith ove … Continued

  • IGHID-World-Logo-Design-Research-New-Academic-Year

    IGHID Investigators Discuss Projects As New Academic Year Begins

    Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be u … Continued

  • kovarova-TB-Study.jpg

    Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

    Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read more.

  • Myron Cohen, MD-ID-faculty-in-covid-news-dec-24-30

    Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

    Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.